Similar articles

• Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.

  Robinson K, Arheart K, Refsum H, Brattström L, Boers G, Ueland P, Rubba P, Palma-Reis R, Meleady R, Daly L, Witteman J, Graham I. Robinson K, et al. Circulation. 1998 Feb 10;97(5):437-43. doi: 10.1161/01.cir.97.5.437. Circulation. 1998. PMID: 9490237
• Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

  Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, Gaziano JM; Veterans Affairs Site Investigators. Jamison RL, et al. JAMA. 2007 Sep 12;298(10):1163-70. doi: 10.1001/jama.298.10.1163. JAMA. 2007. PMID: 17848650 Clinical Trial.
• Homocysteine, vitamins and sex.

  Hockly E, Brown MJ. Hockly E, et al. Eur Heart J. 1999 Sep;20(17):1222-3. doi: 10.1053/euhj.1999.1672. Eur Heart J. 1999. PMID: 10454973 No abstract available.
• [Public health control of hyperhomocysteinemia and its consequences].

  Czeizel E, Kalina A. Czeizel E, et al. Orv Hetil. 2003 Oct 5;144(40):1981-9. Orv Hetil. 2003. PMID: 14626640 Review. Hungarian.
• Homocysteine, vitamins, and vascular disease prevention.

  McCully KS. McCully KS. Am J Clin Nutr. 2007 Nov;86(5):1563S-8S. doi: 10.1093/ajcn/86.5.1563S. Am J Clin Nutr. 2007. PMID: 17991676 Review.